RSC Advances · 2020 · 71 citations · 25 references
PharmacyPharmaceutical AnalysisPharmacologyAnalytical ChemistryChromatographic AnalysisGreen ChemistryAnalytical ChromatographyBioanalytical Method ValidationChromatographic Analysis Of PharmaceuticalsChromatographyLiquid ChromatographyNanoparticle FormulationsAssayAssay SpecificityLinear RegressionNanoparticle PharmacologyPrecisionSolvent OptimizationTablets
+ 1189.4. The proposed RP-HPTLC technique was validated for "precision, accuracy, robustness and sensitivity". The accuracy of the method was obtained as 97.97-99.67%. The % RSD in repeatability and intermediate precision was recorded as 0.46-0.64 and 0.48-0.86%, respectively. The LOD and LOQ for rivaroxaban were obtained as 18.45 and 55.35 ng per spot, respectively. The % content of rivaroxaban in marketed tablets and NPs was recorded as 99.20 and 98.08%, respectively. The proposed RP-HPTLC technique could be successfully applied for the pharmaceutical assay of rivaroxaban in NPs, marketed tablets and related formulations.
25
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
Elise S. Eerenberg, Pieter W. Kamphuisen, Meertien K. Sijpkens et al. · Circulation · 2011 · 1.4K citations · Full text
Susanne Roehrig, Alexander Straub, Jens Pohlmann et al. · Journal of Medicinal Chemistry · 2005 · 433 citations · Full text
Abbas Ostovan, Mehrorang Ghaedi, Maryam Arabi et al. · ACS Applied Materials & Interfaces · 2018 · 341 citations · Full text
Khalid Anwer, Muqtader Mohammad, Farhat Fatima et al. · International Journal of Nanomedicine · 2019 · 149 citations · Full text